Axsome Therapeutics, Inc. (AXSM)
172.97
-1.37
(-0.79%)
USD |
NASDAQ |
Oct 07, 16:00
173.02
+0.05
(+0.03%)
After-Hours: 20:00
Axsome Therapeutics Profit Margin (Quarterly) : -23.50% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -23.50% |
| March 31, 2026 | -33.76% |
| December 31, 2025 | -14.57% |
| September 30, 2025 | -27.62% |
| June 30, 2025 | -31.97% |
| March 31, 2025 | -48.91% |
| December 31, 2024 | -63.08% |
| September 30, 2024 | -61.67% |
| June 30, 2024 | -91.03% |
| Date | Value |
|---|---|
| March 31, 2024 | -91.14% |
| December 31, 2023 | -137.9% |
| September 30, 2023 | -107.6% |
| June 30, 2023 | -143.8% |
| March 31, 2023 | -11.86% |
| December 31, 2022 | -251.3% |
| September 30, 2022 | -266.1% |
| June 30, 2022 | -469.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 30.88% |
| Liquidia Corp. | 43.52% |
| Filana Therapeutics, Inc. | -- |
| CorMedix, Inc. | 25.50% |
| Eloxx Pharmaceuticals, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -256.9% |
| Return on Assets | -27.58% |
| Return on Invested Capital | -64.85% |
| Gross Profit Margin (Quarterly) | 92.47% |
| Operating Margin (Quarterly) | -23.42% |
| Return on Net Operating Assets | -57.00% |